Literature DB >> 30340976

Endoscopic management of Esthesioneuroblastoma: Our experience and review of the literature.

Georgios Klironomos1, Lior Gonen2, Karolyn Au2, Eric Monteiro3, Alireza Mansouri2, Mazda Keki Turel2, Ian Witterick3, Alan Vescan3, Gelareh Zadeh2, Fred Gentili2.   

Abstract

During the last two decades evolution of the endoscopic endonasal approaches (EEA) has offered the option of minimally invasive techniques in the management of esthesioneuroblastomas (ENB), either as endoscope assisted cranial resection or as pure endoscopic procedures. This study presents the use of pure EEA in the management of ENB in our center, along with a literature review. We retrospectively reviewed the clinical, radiology and pathology records of patients with ENB treated during the period July 2006 to January 2016. During the above period, ten patients with ENB were treated using pure EEA. The mean age was 47.5 years. The gender distribution was: eight males, two females. The most common presenting symptoms were nasal obstruction and discharge or epistaxis (8/10). The mean duration of symptoms was 1.5 years. All patients had preoperative confirmation of ENB by biopsy. Five patients received neoadjuvant radiation and four underwent postoperative radiation. One patient did not receive any radiotherapy and no patient received chemotherapy. Gross total resection was achieved in all patients and intraoperative microscopically negative surgical margins achieved in 9/10 (90%). No major intraoperative complications occurred. The most common postoperative complication was nasal infection. Cerebrospinal fluid leak was noted in one patient. During the follow-up period of 6-120 months (mean 74.8) two cases of neck lymph node recurrence were observed. No deaths due to the disease occurred during the follow-up period. Pure EEA offer excellent results in the management of ENB. Neoadjuvant radiation treatment is promising although more studies need to establish its role.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Esthesioneuroblastoma; Expanded endoscopic endonasal approach

Mesh:

Year:  2018        PMID: 30340976     DOI: 10.1016/j.jocn.2018.09.011

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  5 in total

1.  Development and validation of a postoperative nomogram for predicting overall survival after endoscopic surgical management of olfactory neuroblastoma.

Authors:  Jingyi Yang; Xiaole Song; Yuting Lai; Weidong Zhao; Jiaying Zhou; Quan Liu; Wanpeng Li; Huankang Zhang; Huan Wang; Peng Shi; Hongmeng Yu; Xicai Sun; Dehui Wang
Journal:  EClinicalMedicine       Date:  2020-11-30

Review 2.  Exclusively endoscopic surgical resection of esthesioneuroblastoma: A systematic review.

Authors:  Daniel B Spielman; Andi Liebowitz; Maeher Grewal; Chetan Safi; Jonathan B Overdevest; Alfred M Iloreta; Brett E Youngerman; David A Gudis
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2022-03-22

3.  Olfactory Neuroblastoma: Surgical Treatment Experience of 42 Cases.

Authors:  Xiao Cai; Zhouying Peng; Hua Zhang; Ruohao Fan; Yan Fang; Zhihai Xie
Journal:  Front Surg       Date:  2022-02-01

4.  Short-Term Morbidity and Predictors of Adverse Events Following Esthesioneuroblastoma Surgery.

Authors:  Khodayar Goshtasbi; Jack L Birkenbeuel; Mehdi Abouzari; Brandon M Lehrich; Tyler M Yasaka; Arash Abiri; Ethan G Muhonen; Frank P K Hsu; Edward C Kuan
Journal:  Am J Rhinol Allergy       Date:  2020-10-29       Impact factor: 2.467

5.  Delaying Postoperative Radiotherapy in Low-Grade Esthesioneuroblastoma: Is It Worth the Wait?

Authors:  Satoshi Kiyofuji; Vijay Agarwal; Joshua D Hughes; Robert L Foote; Jeffrey R Janus; Eric J Moore; Caterina Giannini; Michael J Link; Jamie J Van Gompel
Journal:  J Neurol Surg B Skull Base       Date:  2020-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.